Clinical Data

• Clinical Data

Viridian tumbles on positive data for key eye drug prospect

pharminent March 31, 2026

• Clinical Data

PepGen Loses Half of Share Price on Mixed Data in Rare Muscle-Wasting Disease

pharminent March 31, 2026

• Clinical Data

Kardigan Blood Pressure Drug Proves Hypothesis Despite Split Phase 2 Readout

pharminent March 30, 2026

• Clinical Data

Biogen’s Lupus Drug Reduces Disease Activity, Further Deresking I&I Pipeline

pharminent March 30, 2026

• Clinical Data

AstraZeneca lung drug gets ‘surprise’ win in COPD trials

pharminent March 27, 2026

• Clinical Data

Wave crashes on obesity drug update; Kodiak’s reboot pays dividends

pharminent March 26, 2026

• Clinical Data

Maze tumbles despite positive data for kidney disease drug

pharminent March 25, 2026

• Clinical Data

Beam posts positive data on base editing treatment for AATD

pharminent March 25, 2026

• Clinical Data

Sarepta sees early success with RNAi drugs from Arrowhead

pharminent March 25, 2026

• Clinical Data

Karyopharm myeloma drug yields mixed data in myelofibrosis trial

pharminent March 24, 2026

• Clinical Data

Apogee strengthens case for longer-lasting eczema drug

pharminent March 23, 2026